Kayne Anderson Rudnick Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-154,294
Closed -$2.99M 362
2018
Q3
$2.99M Buy
154,294
+55,637
+56% +$1.18M 0.02% 228
2018
Q2
$2.52M Buy
98,657
+4,610
+5% +$107K 0.02% 235
2018
Q1
$1.9M Sell
94,047
-1,122
-1% -$26.2K 0.01% 264
2017
Q4
$1.91M Buy
95,169
+8
+0% +$157 0.02% 266
2017
Q3
$1.97M Sell
95,161
-1,361
-1% -$23K 0.02% 260
2017
Q2
$1.43M Buy
96,522
+63,787
+195% +$1.06M 0.01% 276
2017
Q1
$522K Buy
32,735
+6,137
+23% +$88.5K 0.01% 315
2016
Q4
$335K Sell
26,598
-5,706
-18% -$106K ﹤0.01% 321
2016
Q3
$905K Sell
32,304
-720
-2% -$24.2K 0.01% 291
2016
Q2
$1.16M Sell
33,024
-541
-2% -$17K 0.02% 272
2016
Q1
$920K Sell
33,565
-465
-1% -$13.7K 0.02% 274
2015
Q4
$1.17M Buy
+34,030
New +$1.06M 0.02% 262

Other funds holding DPLO

Kayne Anderson Rudnick Investment Management's DPLO Position: Q4 2018 in Review

Kayne Anderson Rudnick Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 154,294 shares — an estimated $2.99M sold.

Kayne Anderson Rudnick Investment Management first reported a position in DPLO in Q4 2015 and held it in 12 quarters. The position peaked at $2.99M in Q3 2018. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Kayne Anderson Rudnick Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 154,294 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $2.99M.
  • Kayne Anderson Rudnick Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 12 quarters.
  • Kayne Anderson Rudnick Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $2.99M in Q3 2018.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.